This report contains market size and forecasts of Pembrolizumab in global, including the following market information:
Global Pembrolizumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pembrolizumab Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pembrolizumab companies in 2021 (%)
The global Pembrolizumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50mg Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pembrolizumab include Merck. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pembrolizumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pembrolizumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pembrolizumab Market Segment Percentages, by Type, 2021 (%)
50mg Injection
100mg Injection
Global Pembrolizumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pembrolizumab Market Segment Percentages, by Application, 2021 (%)
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other
Global Pembrolizumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pembrolizumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pembrolizumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pembrolizumab revenues share in global market, 2021 (%)
Key companies Pembrolizumab sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pembrolizumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck